Cargando…

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer

Bladder preservation with trimodality treatment (TMT) is an alternative strategy to radical cystectomy (RC) for the management of localised muscle invasive bladder cancer (MIBC). TMT comprises of transurethral resection of the bladder tumour (TURBT) followed by radiotherapy with concurrent radiosens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portner, R., Bajaj, A., Elumalai, T., Huddart, R., Murthy, V., Nightingale, H., Patel, K., Sargos, P., Song, Y., Hoskin, P., Choudhury, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385113/ https://www.ncbi.nlm.nih.gov/pubmed/34466667 http://dx.doi.org/10.1016/j.ctro.2021.08.003

Ejemplares similares

Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials
por: Choudhury, Ananya, et al.
Publicado: (2021)

The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
por: Tsang, Yat Man, et al.
Publicado: (2017)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Standard Versus Hypofractionated Radiation Therapy for Bladder Cancer: New Insights, but Questions Remain
por: Baumann, Brian C., et al.
Publicado: (2021)

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
por: Youssief, Ayatallah A, et al.
Publicado: (2022)

Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
por: Sargos, Paul, et al.
Publicado: (2016)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2015)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2016)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.
por: Hoskin, P. J., et al.
Publicado: (1997)

Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
por: Garcia, Maurice M., et al.
Publicado: (2014)

Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?
por: Smelser, Woodson Wade, et al.
Publicado: (2017)

Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes
por: Garcia, Maurice M., et al.
Publicado: (2016)

Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients
por: Arafat, Waleed, et al.
Publicado: (2016)

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
por: Orré, Mathieu, et al.
Publicado: (2017)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

Bladder preservation in muscle-invasive bladder cancer: a comprehensive review
por: Hamad, Judy, et al.
Publicado: (2020)

Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder
por: Michaelson, M D, et al.
Publicado: (2004)

Mapping Local Failure Following Bladder Radiotherapy According to Dose
por: Abdel-Aty, H., et al.
Publicado: (2022)

The Rationale for Post-Operative Radiation in Localized Bladder Cancer
por: Baumann, Brian C., et al.
Publicado: (2017)

Management of recurrent localised bladder amyloid, has methotrexate helped?
por: Kelsey, E., et al.
Publicado: (2023)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
por: Mitchell, A., et al.
Publicado: (2022)

Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer—a valid option for cisplatin-unfit patients?
por: Arnold, C. R., et al.
Publicado: (2021)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhiyu, Zhang, et al.
Publicado: (2021)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
por: Elsayed, Dalia Hamouda, et al.
Publicado: (2023)

The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004)
por: Choudhury, Ananya, et al.
Publicado: (2017)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
por: Hunt, A., et al.
Publicado: (2020)

Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment
por: Hafeez, Shaista, et al.
Publicado: (2017)

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database
por: Fischer-Valuck, Benjamin W., et al.
Publicado: (2018)

Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review
por: Bos, Manouk K., et al.
Publicado: (2014)

Advances in bladder cancer imaging
por: Hafeez, Shaista, et al.
Publicado: (2013)

The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
por: Miyata, Haruka, et al.
Publicado: (2020)

Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience
por: Gerardi, Marianna A., et al.
Publicado: (2016)

Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response
por: Daro-Faye, Mame, et al.
Publicado: (2020)

The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011)
por: Moynihan, Clare, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0b3n62sgj76umuab3uv9mae3sv